When it was in development, the cholesterol-lowering medicine was viewed as such an also-ran it almost didn't make it into patient testing. By the time Lipitor went on sale in early 1997, it was the ...

Feb 14 (Reuters) - Pfizer PFE.N has agreed to pay $93 million to settle antitrust claims by wholesale drug distributors that accused it of conspiring with India's Ranbaxy Laboratories to delay sales ...

Cholesterol disorders affect millions of people globally and are among the leading risk factors for cardiovascular diseases, including heart attack and stroke. Statins are the first-line therapy for ...

More than 140,000 bottles of a popular drug commonly prescribed to reduce cholesterol have been recalled for a defect that ...

NEW YORK (Reuters) - It may take a breakthrough treatment for Alzheimer's disease to match the $130 billion lifetime sales record of Pfizer's Lipitor, the cholesterol fighter that wrote its own ...